Actively Recruiting
Lifestyle Intervention for Symptoms of Depression wIth App Support in General Practice
Led by Radboud University Medical Center · Updated on 2025-12-22
216
Participants Needed
3
Research Sites
84 weeks
Total Duration
On this page
Sponsors
R
Radboud University Medical Center
Lead Sponsor
I
Ixta Noa
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to find out whether a smartphone app can help reduce symptoms of depression by supporting healthy lifestyle changes and encouraging self-monitoring in adults who visit their general practitioner with symptoms of depression. The main questions this study aims to answer are: Does a personalized lifestyle intervention delivered through the app, in addition to regular care, reduce depression symptoms more effectively than regular care alone? Is this approach more cost-effective than regular care alone? Researchers will compare patients who use the app alongside their regular care to patients who receive regular care without the app, to see whether the app leads to better outcomes. Participants who use the app will: Complete a lifestyle questionnaire focused on six themes: mental wellbeing, use of harmful substances, social relationships, healthy eating, sleep, and physical activity. Set personal goals based on their results and receive tailored lifestyle advice. Track their depression symptoms regularly within the app to support ongoing care. Have follow-up conversations with their general practitioner or mental health nurse to discuss their progress. Fill out questionnaires about their symptoms and experiences during the study.
CONDITIONS
Official Title
Lifestyle Intervention for Symptoms of Depression wIth App Support in General Practice
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Currently experiencing an episode of symptoms of depression and receiving treatment for this episode from their GP or GP-MHW for less than six months
- Have a smartphone
- Be proficient in Dutch
You will not qualify if you...
- Severe mental illness (such as psychosis or bipolar disorder)
- Severe alcohol or drug addiction requiring specialized secondary care
- High suicide risk
- moderate to severe cognitive impairment (as determined by the GP)
Patients who visit their GP for depressive symptoms but with a PHQ-9 of <5 at baseline are allowed to use the PLI, but will not be included in the primary analysis.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Radboudumc
Nijmegen, Gelderland, Netherlands, 6525GA
Actively Recruiting
2
Amsterdam UMC
Amsterdam, North Holland, Netherlands, 1105 AZ
Actively Recruiting
3
UMC Groningen
Groningen, Provincie Groningen, Netherlands, 9713 GZ
Actively Recruiting
Research Team
E
Eline Jagtenberg
CONTACT
S
Suzanne Ligthart
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here